Search Login Register
Xerophthalmia
Summary
Description:
Dryness of the eye surfaces caused by deficiency of tears or conjunctival secretions. It may be associated with vitamin A deficiency, trauma, or any condition in which the eyelids do not close completely.
Also Known As:
Xerophthalmias
Networked: 242
relevant articles (15 outcomes,
20 trials/studies)
for this Disease
Key Drugs and Agents for Xerophthalmia
Efficacy Chart >>
Drugs and Important Biological Agents (IBA) related to treatments:
-
Vitamin A (Retinol)
:
7 outcomes 12 studies in 115 results
:
FDA 33
Generic
-
Tretinoin (Retinoic Acid)
:
3 outcomes in 8 results
:
FDA 27
Generic
-
cevimeline (Evoxac)
:
2 outcomes in 2 results
:
FDA 1
-
Carbon Monoxide
:
1 outcome 1 study in 3 results
: IBA
-
SS-B antibodies
:
1 outcome in 2 results
: IBA
-
Muscarinic M3 Receptor
:
1 outcome in 1 result
: IBA
-
Interferon-alpha (Interferon Alfa)
:
1 outcome in 1 result
:
FDA 2
-
Vitamin D
:
1 outcome in 1 result
:
FDA 10
Generic
-
Sodium Glutamate (Accent)
:
1 outcome in 1 result
: IBA
-
Ivermectin (Mectizan)
:
1 outcome in 1 result
:
FDA 1
Show All >>
Diseases Related to Xerophthalmia
-
Xerostomia
-
Sjogren's Syndrome (Sjogren Syndrome)
-
Wounds and Injuries (Trauma)
-
Vitamin A Deficiency
-
Night Blindness (Nyctalopia)
Show All >>
Key Therapies for Xerophthalmia
Efficacy Chart >>
-
Aftercare (After-Treatment)
:
1 outcome in 3 results
-
Oral Administration
:
1 outcome in 2 results
-
Transplantation (Transplant Recipients)
:
1 study in 16 results
-
Acupuncture Therapy
:
1 study in 1 result
-
Moxibustion
:
3 results
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.